CN1265781C - Self-solidifying calcium phosphate filling material for canalis radicis dentis - Google Patents
Self-solidifying calcium phosphate filling material for canalis radicis dentis Download PDFInfo
- Publication number
- CN1265781C CN1265781C CNB031152511A CN03115251A CN1265781C CN 1265781 C CN1265781 C CN 1265781C CN B031152511 A CNB031152511 A CN B031152511A CN 03115251 A CN03115251 A CN 03115251A CN 1265781 C CN1265781 C CN 1265781C
- Authority
- CN
- China
- Prior art keywords
- root
- calcium phosphate
- medicine
- filling
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Dental Preparations (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a self-solidifying calcium phosphate filling agent for root canals and an application method thereof. The present invention mixes calcium phosphate salt and a proper developer and introduces medicine with a curative effect particularly anti-anaerobic bacterium medicine; then, an anhydrous atoxic solvent is used for preparing the medicine into a toothpaste shape or a pasty shape; a pasty article is filled in an injector for the injection treatment of a root canal. The main component of the whole paste is calcium phosphate composite powder which is neuter in water solution. The slowing process of the calcium phosphate composite powder is a slow neuter hydration reaction process without other stimuli. The hydrated final component of the whole paste is hydroxyapatite similar to the inorganic component of sclerous tissue of a human body. The present invention has the advantages of good biocompatibility and no stimulation. Therefore, after the root canal is filled, even if the root canal is excessively filled, a root filling reaction can not generate; the part of excessively filling in alveolar bone can be gradually absorbed by phatnomas for guiding the formation of new bone. The effect of the present invention is superior to that of the existing other types of root canal filling products. The present invention changes the traditional concept of root canal filling.
Description
Technical field
The invention belongs to field of medical materials, relate to a kind of novel pipe filler for the treatment of diseases such as pulpitis, tooth periapical periodontitis.
Background technology
Root-canal filling is one of effective ways of treatment periapical periodontitis and dental pulp disease, and the performance of root canal filling material directly affects the effect of root-canal filling in the treatment, becomes the key of root canal success.Along with development of technology, traditional phenolic filler is abandoned gradually, and new paste class material has obtained application clinical.Relate in research and the clinical practice at present more have following several:
The existing long time of 1 zinc oxide eugenol paste zinc oxide paste application clinically, eugenol wherein has anti-microbial property, most amphimicrobes and minority anaerobe all there is in various degree inhibitory action (Torabinejad M, et al., Jendod, 1995,21 (8): 403), yet it toxicly be studies show that further zinc oxide paste does not reach the desired inertia of ideal root canal filling material and has no side effect;
2 Ca (OH)
2(1992,8 (5): 183) the report calcium hydroxide can make local environment be the meta-alkalescence state to the root canal filling paste document, reduces the vigor of absorptive cell, promotes sclerous tissues to form for Trope M., Endod DentTraumatol; Calcium ion can form calcium phosphate crystal with the apatite-base qualitative response in the dentin in addition, and sealing dentinal tubule reduces the existence of antibacterial.The cytotoxicity of calcium hydroxide has absorbability less than zinc oxide eugenol paste, but its tip of a root that can only be used for young permanent teeth is induced shaping;
3 iodoform paste iodoform pastes are applicable to that pus is many, exudate is many, immature of the tip of a root is managed and the filling of newborn root canal.After iodoform and alcohol, tissue fluid, fat or antibacterial produce and contact, slowly decompose and produce free-iodine, thereby make the bacterial product oxidation, the generation bactericidal action; In addition, the root-canal filling of utilization iodoform paste may cause patient's systemic anaphylaxis.
Calcium phosphate bone cement (CPC) is a kind of novel hard tissue repairing material, by solid-liquid two phase compositions, can reconcile into pastel, and is moulding arbitrarily according to defect.Its good biocompatibility, under the environment of human body and temperature conditions, solidify voluntarily, its aquation composition finally is converted into hydroxyapatite (hydroxyapatite HAP), can guide osteogenesis, progressively be organized and absorb and generation bone regeneration effect present orthopaedics clinical practice result satisfactory (old system first-class, Chinese wound magazine, 1999,15 (3): 184-86).
Super the filling of material is the main difficult problem of root canal always, and traditional material is super can to cause swelling, pain after filling, and is the main cause that causes the root canal failure; And the super part of filling of CPC material can be organized absorption, vacuum response, and play the effect that guides the periapical osteanagenesis, changed the traditional concept of root canal.
The technical issues that need to address of the present invention are to disclose a kind of self-curable calcium phosphate root pipe filler, the mode that this root pipe filler can be taked to inject is filled, and makes things convenient for the doctor to operate, and improves therapeutic effect, alleviate even eliminate root and fill reaction, solve the root pipe and fill the treatment problem.
Technical conceive of the present invention is such: calcium phosphate bone cement and root canal wall adaptation are good, can diffuse in the tube wall dentinal tubule.Change in volume does not take place in curing voluntarily in the root pipe, increases the mechanical strength of root of the tooth, reduces the probability of root folding, can play the effect of osteanagenesis on every side of the guiding tip of a root effectively.
Synthos are mixed with appropriate developer, and introduce medicine, particularly anti-anaerobic agent, reconcile into toothpaste-like or thick paste with anhydrous innoxious solvent then with therapeutic effect, this thick paste thing is circulated in the syringe, promptly can be used for the injection for curing of root canal.
The detailed technical scheme of the present invention is as described below:
The component of Injectable self-curable calcium phosphate root pipe filler of the present invention comprises the developing agent and the stabilizing agent of compound phosphoric acid calcium salt, effective dose, and its preferred ratio is:
Compound phosphoric acid calcium salt: developing agent: medicine: stabilizing agent=10: 0～10.0: 0～3.0: 0.05～1.0, mass ratio;
Said compound phosphoric acid calcium salt is by the blended by a certain percentage mixture of several calcium phosphate, can be by (US5525148, US5545254) disclosed method preparation can be a kind of in calcium phosphate (α type or β type), the tetracalcium phosphate or both mixture; OCP, calcium hydrogen phosphate (water of crystallization is arranged or do not have water of crystallization, DCPD or DCPA), hydroxyapatite, fluor-apatite, a kind of in the calcium pyrophosphate or their mixture, wherein synthos particles of powder size should be less than 10 microns.
The particle diameter of tetracalcium phosphate is 1～20 micron in the said compound phosphoric acid calcium salt powder, and the particle diameter of DCPA is 1～10 micron.
Said developing agent is iodoform, barium sulfate etc., is good with iodoform wherein.It not only has the development effect, can also sterilize simultaneously.The particle requirement of all powder is little, must not be greater than 100 μ m.
Said medicine is the antibiotic and sterilizing medicine, as tobramycin, safe energy, metronidazole and tinidazole, wherein with tinidazole the best.
Said stabilizing agent is ethoxy or hydroxypropyl cellulose, polyvinyl alcohol, polyvinylpyrrolidone etc., wherein with polyvinylpyrrolidone the best.
Of the present invention pipe filler and solvent are in harmonious proportion and become pasty state, can adopt the mode of filling, also can adopt syringe to carry out the direct injection filling, are the best in injectable mode wherein.
Root pipe filler and solvent ratios are as follows:
Root pipe filler: solvent=10: 2.0～10.0, mass ratio;
Said solvent is glycerol, Polyethylene Glycol or dimethyl silscone wet goods, wherein with dimethicone the best.
The present invention has following advantage:
After 1 anhydrous mastic enters human body, exchange by tissue fluid with surrounding tissue, slowly hardening behind the synthos powder one chance water, but effective closure root pipe and the root pipe had certain invigoration effect, be in non-aqueous media, progressively to solidify simultaneously, firming body intensity is lower, also is easier to where necessary paste is taken out, and is beneficial to the successive treatment operation.
The main component of 2 whole pastes is a calcium phosphate composite powder.Be neutral in aqueous solution, its slack-off process is neutral slowly aquation course of reaction, does not have other stimulus object, and the ultimate constituent after the aquation is hydroxyapatite, and is similar to the inorganic constituents of human body hard tissue, good biocompatibility, nonirritant.Therefore even super filling can not produce root yet and fill reaction after inserting the root pipe, super part of filling in alveolar bone can be progressively by frontal resorption, the formation of guiding area of new bone, its effect is better than existing other types root-canal filling product, has changed the traditional concept that the root pipe is filled.
Contain part antibiotic and sterilizing medicine in 3 pipes, can local long-acting slow-releasing medicine, local concentration is better, but systemic drug concentration is very little, thereby reaches antibiotic, and root canal course of treatment is simplified in disinfective action, shortens treatment cycle.
4 oxpara particle diameters of the present invention are little, and fluidity of slurry and good stability are not stratified in the medium-term and long-term preservation of injection needle, and not phase-splitting can be used for injecting the root pipe and fills treatment.When using, can adopt by need the method for injection to carry out.But shear thinning, good fluidity, resistance are little under external force during injection, and the injection needle point only need be inserted into 1/3rd places of root pipe when injecting the root pipe.Paste still can arrive the root canal tip of a root well under injection pressure, fills sealing root pipe effectively, reaches the purpose of eliminating dead space.Even tiny canal, crooked root tube, branched root pipe also are so, make things convenient for clinical manipulation greatly, reduce and expand root and padding specification requirement, improve therapeutic effect.
The specific embodiment
Further illustrate content of the present invention below in conjunction with example, but these examples do not limit protection scope of the present invention.
Embodiment 1
Take by weighing the particle diameter that contains calcium hydrogen phosphate, tetracalcium phosphate and hydroxyapatite compound phosphoric acid calcium salt powder 10g less than 10 μ m, tinidazole 0.5g, Polyethylene Glycol-400 0.1g composition mixture reconciles into pastel with the anhydrous dimethyl silicone oil of 10g with it, joins in the syringe.This pastel is easy to injection, good stability; The root pipe is sealed in injection not stratified, the not phase-splitting in back effectively, has played sterilization, anticorrosion astringent effect.
Embodiment 2
Take by weighing the particle diameter formed by calcium hydrogen phosphate, tetracalcium phosphate and hydroxyapatite compound phosphoric acid calcium salt powder 10g less than 10 μ m, tinidazole 0.5g, glycerol 0.1g composition mixture reconciles into pastel with the anhydrous dimethyl silicone oil of 10g with it, joins in the syringe.This pastel is easy to injection, good stability; The root pipe is sealed in injection not stratified, the not phase-splitting in back effectively, has played sterilization, anticorrosion astringent effect.
Embodiment 3
Embodiment 1 described oxpara is sent in the root canal, 108 cases suffering from dental pulp disease and periapical disease have been carried out filling, have 121 teeth, 221 roots of the tooth.Women's 65 examples wherein, male's 43 examples, 41.52 years old mean age, were followed up a case by regular visits to time 12-25 month at age 9-66 year.Untoward reaction does not all take place clinically, the tooth invariant color, change in volume does not take place in the root casing pack.Also all do not have postoperative pain even surpass the part tooth that fills, roots such as local gingiva hyperemia, edema dash reaction and occur, and material has played the effect of osteanagenesis on every side of the guiding tip of a root effectively.
Claims (4)
1. self-curable calcium phosphate root pipe filler, it is characterized in that comprising developing agent, medicine, stabilizing agent and the solvent of compound phosphoric acid calcium salt, effective dose, the quality of each component than ratio is: compound phosphoric acid calcium salt: developing agent: medicine: stabilizing agent=10: 0～10.0: 0～3.0: 0.05～1.0;
Root pipe filler and solvent ratios are as follows:
Root pipe filler: solvent=10: 2.0～10.0, mass ratio;
Solvent is glycerol, Polyethylene Glycol or dimethyl silicone oil;
Said stabilizing agent is ethoxy or hydroxypropyl cellulose, polyvinyl alcohol, polyvinylpyrrolidone.
2. according to claim 1 pipe filler is characterized in that said developing agent is iodoform or barium sulfate.
3. according to claim 1 pipe filler is characterized in that said medicine is the antibiotic and sterilizing medicine.
4. according to claim 3 pipe filler is characterized in that, medicine is selected from tobramycin, safe energy, metronidazole and tinidazole.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031152511A CN1265781C (en) | 2003-01-29 | 2003-01-29 | Self-solidifying calcium phosphate filling material for canalis radicis dentis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031152511A CN1265781C (en) | 2003-01-29 | 2003-01-29 | Self-solidifying calcium phosphate filling material for canalis radicis dentis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1446530A CN1446530A (en) | 2003-10-08 |
| CN1265781C true CN1265781C (en) | 2006-07-26 |
Family
ID=28050413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031152511A Expired - Fee Related CN1265781C (en) | 2003-01-29 | 2003-01-29 | Self-solidifying calcium phosphate filling material for canalis radicis dentis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1265781C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102105117A (en) * | 2008-05-30 | 2011-06-22 | 何塞·路易斯·何塞·查弗尔 | Process for laser treatment of dental caries, biomaterial for realisation and use thereof |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0403020D0 (en) | 2004-12-13 | 2004-12-13 | Rickard Braanemark | Implant |
| CN100400025C (en) * | 2006-03-03 | 2008-07-09 | 厦门大学 | Root canal filling paste capable of being stored and injected |
| EP2452667A1 (en) * | 2010-11-15 | 2012-05-16 | Septodont ou Septodont SAS ou Specialites Septodont | Endodontic sealing composition |
| EP2572698A1 (en) | 2011-09-21 | 2013-03-27 | Septodont ou Septodont SAS ou Specialites Septodont | Wear resistant dental composition |
| CN103520004A (en) * | 2012-07-05 | 2014-01-22 | 宁存德 | Shellac root canal filling agent |
| CN107080697B (en) * | 2017-03-31 | 2020-10-16 | 烟台正海生物科技股份有限公司 | Stable-suspension premixed calcium silicate-based root canal filling material and preparation method and application thereof |
| CN110882166A (en) * | 2019-12-10 | 2020-03-17 | 广州润虹医药科技股份有限公司 | Stable calcium phosphate root canal filler |
| CN110772430A (en) * | 2019-12-11 | 2020-02-11 | 广州润虹医药科技股份有限公司 | Calcium phosphate root canal filler with stable preservation |
| CN110934750A (en) * | 2019-12-27 | 2020-03-31 | 广州润虹医药科技股份有限公司 | Root canal filler for treating pulpitis or periapicalitis and preparation method thereof |
| CN113750289B (en) * | 2021-10-20 | 2022-11-29 | 香港大学深圳医院 | Organic-inorganic composite bioactive material based on calcium phosphate and preparation method thereof |
| CN114288042B (en) * | 2021-12-29 | 2024-07-23 | 复旦大学附属中山医院 | Root canal filling core for layered medicine carrying and slow releasing |
-
2003
- 2003-01-29 CN CNB031152511A patent/CN1265781C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102105117A (en) * | 2008-05-30 | 2011-06-22 | 何塞·路易斯·何塞·查弗尔 | Process for laser treatment of dental caries, biomaterial for realisation and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1446530A (en) | 2003-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1265781C (en) | Self-solidifying calcium phosphate filling material for canalis radicis dentis | |
| CN103142418B (en) | Root canal is filled with calcium phosphate magnesium base composite material and preparation method thereof | |
| Asgary et al. | Periradicular regeneration after endodontic surgery with calcium-enriched mixture cement in dogs | |
| US8105086B2 (en) | Medical and dental biomaterial and method of use for the same | |
| KR101363881B1 (en) | Dental and endodontic filling materials and methods | |
| Sonat et al. | Periapical tissue reaction to root fillings with Sealapex | |
| KR20210044168A (en) | Filler compositions | |
| Chonat et al. | Obturating materials in primary teeth—a review | |
| Bansode et al. | Obturating materials present and past: a review | |
| Bhagat et al. | Root end filling materials and recent advances: a review | |
| JP2009542575A (en) | Novel phosphorus-calcium-strontium compounds and their use in endodontic cement | |
| Berbert et al. | Influence of root canal dressings and sealers on repair of apical periodontitis after endodontic treatment | |
| Prashanth | Recent advancements in medicated root canal sealers: An advanced step in creating bacteria free obturation | |
| Deshpande et al. | Comprehensive review on recent root canal filling materials and techniques–An update | |
| Teixeira et al. | Gutta-percha: the end of an era | |
| Sharma et al. | Recent advancements in root canal sealers-An overview | |
| CN100998543A (en) | Oral root canal sealing medicine and preparation method thereof | |
| MASSLER | Biologic considerations in the selection and use of restorative materials | |
| Abrishami et al. | Historical Perspectives on the Evolution of Root Canal Sealer/Cements | |
| Chong et al. | Root Canal Filling Materials and Techniques | |
| CN115887233A (en) | Root canal filling paste and method of use thereof | |
| Megasari et al. | The evaluation of setting time and ftir spectroscopy of carbonate apatite cement as endodontic sealer | |
| RU2370238C1 (en) | Method of apical periodontitis treatment | |
| Jayakumar et al. | MTA: A review of literature with clinical applications | |
| CN110882166A (en) | Stable calcium phosphate root canal filler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060726 Termination date: 20110129 |